Therapeutic target identified to neutralize toxic forms of Parkinson's-associated protein

Medical Xpress

Center

High Factuality

Therapeutic target identified to neutralize toxic forms of Parkinson's-associated protein

Researchers from the UAB have identified a region in the early aggregates of the alpha-synuclein protein that can be targeted to prevent its conversion into the toxic amyloid fibrils that accumulate in the brains of people suffering from Parkinson's disease.